Therefore, it is important to carry out further research to determine whether the distinct effect of TMZ in stimulating KCC2 activity in glioblastoma cells is due to a patient-specific impact of TMZ in promoting KCC2 activity in cells and the relationship of this with the efficacy of tumor treatment. The gene discussed is SLC12A5; the disease is glioblastoma.